Global Self-Injections Market is expected to reach USD 79.5 billion by 2022, from USD 19.1 billion in 2015 growing at a CAGR of 22.6% during the forecast period of 2016 to 2022.
Global Self-Injections Market is segmented based on product types, dosage form, therapeutic application, route of administration, end-user, distribution channel, and geography.
For Sample Report: http://databridgemarketresearch.com/reports/global-self-injections-market-trends-forecast-2022/
On the basis of type, the global self-injections market is segmented into devices and formulations. The devices market is segmented into needle-free injectors, auto injectors, pen injectors, wearable injectors, and other devices. The formulations market is segmented into conventional drug delivery formulations, novel drug delivery formulations, and long-acting formulations.
On the basis of dosage the self injections market is segmented into into single dose and multi dose.
Based on therapeutic application, the market is segmented into autoimmune diseases, hormonal disorders, oncology, orphan diseases, pain management, respiratory therapy, and others.
To read more about the scope and findings of this report visit: http://databridgemarketresearch.com/self-injections-market-poised-grow-22-6/
On the basis of route of administration, the market is segmented into skin, circulatory /musculoskeletal, organs, and central nervous system.
Based on end-user, the market is segmented into patient, physicians, home care settings and, others.
On the basis of distribution channel the market is segmented into hospital pharmacies, private clinics, chemist, and online pharmacies.
Based on geography, the market report covers data for regions namely North America, Europe, Asia-Pacific, South America, Middle East and Africa and, Rest of the World. The report of this market shares countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa.
Global players operating in this market are players operating in this market are Abbvie, Inc., Antares Pharma, 3M, Becton Dickinson & Company, Baxter International Inc., Penjet Corporation, PharmaJet, Gerresheimer AG, Pfizer Inc., Terumo Corporation, Mylan Specialty L.P., SHL Group, Bespak, Janssen Biotech, Inc., Insulet Corporation, Unilife Corporation, West Pharmaceutical Services, Inc., Ypsomed, among other companies.
To Browse Full Report and Pricing: http://databridgemarketresearch.com/reports/global-self-injections-market-trends-forecast-2022/
Table of Content:
1 INTRODUCTION
1.1. OVERVIEW OF THE SELF-INJECTIONS MARKET
1.2. MARKET SEGMENTATION & COVERAGE
1.2.1. CURRENCY AND PRICING
1.2.2. LIMITATION
1.2.3. STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1. KEY TAKEAWAYS
2.2. ARRIVING AT THE GLOBAL SELF-INJECTIONS MARKET
2.2.1. MARKET CRACKDOWN APPROACH
2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS
2.2.3. DATA TRIANGULATION
2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES
2.2.5. KEY DATA POINTS FROM SECONDARY SOURCES
2.2.6. PORTER’S FIVE FORCES MATRIX
2.4. GLOBAL SELF-INJECTIONS MARKET: RESEARCH SNAPSHOT
2.5. ASSUMPTIONS
3 MARKET LANDSCAPE SUMMARY
4 PREMIUM INSIGHTS
4.1. OVERVIEW
4.2. GLOBAL SELF-INJECTIONS MARKET: KEY PRIMARY INSIGHTS
4.3. MARKET OVERVIEW
4.4. KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES
5 SELF-INJECTIONS MARKET, BY TYPE
5.1. OVERVIEW
5.2. DEVICES
5.3. FORMULATIONS
6 SELF-INJECTIONS MARKET, BY DOSAGE FORM
6.1. OVERVIEW
6.2. SINGLE DOSE
6.3. MULTI-DOSE
7 SELF-INJECTIONS MARKET, BY THERAPEUTIC APPLICATION
7.1. OVERVIEW
7.2. AUTOIMMUNE DISEASES
7.3. HORMONAL DISORDERS
7.4. ONCOLOGY
7.5. ORPHAN DISEASES
7.6. PAIN MANAGEMENT
7.7. RESPIRATORY THERAPY
7.8. OTHERS
8 SELF-INJECTIONS MARKET, BY ROUTE OF ADMINISTRATION
8.1. OVERVIEW
8.2. SKIN
8.3. CIRCULATORY/MUSCULOSKELETAL
8.4. ORGANS
8.5. CENTRAL NERVOUS SYSTEM
9 SELF-INJECTIONS MARKET, BY END-USER
9.1. OVERVIEW
9.2. PATIENT
9.3. PHYSICIANS
9.4. HOME CARE SETTINGS
9.5. OTHERS
10 SELF-INJECTIONS MARKET, BY DISTRIBUTION CHANNEL
10.1. OVERVIEW
10.2. HOSPITAL PHARMACIES
10.3. PRIVATE CLINICS
10.4. CHEMIST
10.5. ONLINE PHARMACIES
11 SELF-INJECTIONS MARKET, BY GEOGRAPHY
11.1. COUNTRYWISE SELF-INJECTIONS MARKET,
(ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
11.1.1. NORTH AMERICA
11.1.1.1. U.S.
11.1.1.2. CANADA
11.1.1.3. MEXICO
11.1.2. EUROPE
11.1.2.1. GERMANY
11.1.2.2. FRANCE
11.1.2.3. U.K.
11.1.2.4. ITALY
11.1.2.5. SPAIN
11.1.2.6. RUSSIA
11.1.2.7. TURKEY
11.1.2.8. BELGIUM
11.1.2.9. NETHERLANDS
11.1.2.10. SWITZERLAND
11.1.2.11. REST OF EUROPE
11.1.3. ASIA-PACIFIC (APAC)
11.1.3.1. JAPAN
11.1.3.2. CHINA
11.1.3.3. SOUTH KOREA
11.1.3.4. INDIA
11.1.3.5. AUSTRALIA
11.1.3.6. SINGAPORE
11.1.3.7. THAILAND
11.1.3.8. MALAYSIA
11.1.3.9. INDONESIA
11.1.3.10. PHILIPPINES
11.1.3.11. REST OF APAC
11.1.4. LATIN AMERICA
11.1.5. MIDDLE EAST AND AFRICA
11.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
12 SELF-INJECTIONS MARKET: COMPETITIVE LANDSCAPE
12.1. GLOBAL SELF-INJECTIONS MARKET: COMPANY SHARE ANALYSIS
12.2. U.S. SELF-INJECTIONS MARKET: COMPANY SHARE ANALYSIS
12.3. EUROPE SELF-INJECTIONS MARKET: COMPANY SHARE ANALYSIS
12.4. ASIA-PACIFIC SELF-INJECTIONS MARKET: COMPANY SHARE ANALYSIS
12.5. MERGERS & ACQUISITIONS
12.6. NEW PRODUCT DEVELOPMENT & APPROVALS
12.7. EXPANSIONS
12.8. REGULATORY CHANGES
12.9. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
13 SELF-INJECTIONS MARKET, COMPANY PROFILES
13.1 BAXTER INTERNATIONAL INC.
13.1.1 OVERVIEW
13.1.2 SWOT ANALYSIS
13.1.3 PRODUCT PORTFOLIO
13.1.4 REVENUE ANALYSIS
13.1.5 ANALYSTS VIEW
13.2 BECTON DICKINSON & COMPANY
13.2.1 OVERVIEW
13.2.2 SWOT ANALYSIS
13.2.3 PRODUCT PORTFOLIO
13.2.4 REVENUE ANALYSIS
13.2.5 ANALYSTS VIEW
13.3 ANTARES PHARMA
13.3.1 OVERVIEW
13.3.2 SWOT ANALYSIS
13.3.3 PRODUCT PORTFOLIO
13.3.4 REVENUE ANALYSIS
13.3.5 ANALYST VIEW
13.4 ABBVIE, INC.
13.4.1 OVERVIEW
13.4.2 SWOT ANALYSIS
13.4.3 PRODUCT PORTFOLIO
13.4.4 REVENUE ANALYSIS
13.4.5 ANALYSTS VIEW
13.5 3M
13.5.1 OVERVIEW
13.5.2 SWOT ANALYSIS
13.5.3 PRODUCT PORTFOLIO
13.5.4 REVENUE ANALYSIS
13.5.5 ANALYSTS VIEW
13.6 PENJET CORPORATION
13.6.1 OVERVIEW
13.6.2 SWOT ANALYSIS
13.6.3 PRODUCT PORTFOLIO
13.6.4 REVENUE ANALYSIS
13.6.5 ANALYSTS VIEW
13.7 PHARMAJET
13.7.1 OVERVIEW
13.7.2 SWOT ANALYSIS
13.7.3 PRODUCT PORTFOLIO
13.7.4 REVENUE ANALYSIS
13.7.5 ANALYSTS VIEW
13.8 PFIZER INC.
13.8.1 OVERVIEW
13.8.2 SWOT ANALYSIS
13.8.3 PRODUCT PORTFOLIO
13.8.4 REVENUE ANALYSIS
13.8.5 ANALYSTS VIEW
13.9 TERUMO CORPORATION
13.9.1 OVERVIEW
13.9.2 SWOT ANALYSIS
13.9.3 PRODUCT PORTFOLIO
13.9.4 REVENUE ANALYSIS
13.9.5 ANALYSTS VIEW
13.10 MYLAN SPECIALTY L.P.
13.10.1 OVERVIEW
13.10.2 SWOT ANALYSIS
13.10.3 PRODUCT PORTFOLIO
13.10.4 REVENUE ANALYSIS
13.10.5 ANALYSTS VIEW
13.11 WEST PHARMACEUTICAL SERVICES, INC.
13.11.1 OVERVIEW
13.11.2 SWOT ANALYSIS
13.11.3 PRODUCT PORTFOLIO
13.11.4 REVENUE ANALYSIS
13.11.5 ANALYSTS VIEW
13.12 JANSSEN BIOTECH, INC.
13.12.1 OVERVIEW
13.12.2 SWOT ANALYSIS
13.12.3 PRODUCT PORTFOLIO
13.12.4 REVENUE ANALYSIS
13.12.5 ANALYSTS VIEW
13.13 INSULET CORPORATION
13.13.1 OVERVIEW
13.13.2 SWOT ANALYSIS
13.13.3 PRODUCT PORTFOLIO
13.13.4 REVENUE ANALYSIS
13.13.5 ANALYSTS VIEW
13.14 YPSOMED
13.14.1 OVERVIEW
13.14.2 SWOT ANALYSIS
13.14.3 PRODUCT PORTFOLIO
13.14.4 REVENUE ANALYSIS
13.14.5 ANALYSTS VIEW
13.15 BESPAK
13.15.1 OVERVIEW
13.15.2 SWOT ANALYSIS
13.15.3 PRODUCT PORTFOLIO
13.15.4 REVENUE ANALYSIS
13.15.5 ANALYSTS VIEW
13.16 SHL GROUP
13.16.1 OVERVIEW
13.16.2 SWOT ANALYSIS
13.16.3 PRODUCT PORTFOLIO
13.16.4 REVENUE ANALYSIS
13.16.5 ANALYSTS VIEW
13.17 GERRESHEIMER AG
13.17.1 OVERVIEW
13.17.2 SWOT ANALYSIS
13.17.3 PRODUCT PORTFOLIO
13.17.4 REVENUE ANALYSIS
13.17.5 ANALYSTS VIEW
13.18 HASELMEIER
13.18.1 OVERVIEW
13.18.2 SWOT ANALYSIS
13.18.3 PRODUCT PORTFOLIO
13.18.4 REVENUE ANALYSIS
13.18.5 ANALYSTS VIEW
13.19. UNILIFE CORP.
13.19.1 OVERVIEW
13.19.2 SWOT ANALYSIS
13.19.3 PRODUCT PORTFOLIO
13.19.4 REVENUE ANALYSIS
13.19.5 ANALYSTS VIEW
14 APPENDIX
15 ABOUT DATA BRIDGE MARKET RESEARCH
About Data Bridge Market Research:
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are one of the largest market research firms in terms of number of reports produced, also we are proud to be the makers of the lengthiest reports in the industry owing to our in depth segmentation and large geographical coverage. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Related Reports:
Global Drug Delivery Devices Market – Trends and Forecast to 2022
By Product Type (Oral (Solid, Liquid,Semi-Solid), Injectable (Devices (Conventional, Self-Injectable), Formulations), Topical (Transdermal Devices (Patches, Gels), Formulations), Pulmonary (MDI, DPI, Nebulizers), Nasal, Ocular, Implantable, Transmucosal), By End-User (Hospitals, Clinics, Home Healthcare, Community Healthcare, Others), By Distribution Channel (Hospital Pharmacy, Pharmacy Stores, Direct Tenders, Online Pharmacy), By Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa, Rest of the World) – Trends and Forecast to 2022
Global Cord Stem Cell Banking Market – Trends and Forecast to 2022
By Storage Type (Private Banking, Public Banking), By Product Type (Cord Blood, Cord Blood & Cord Tissue), By Service Type (Collection & Transportation, Processing, Analysis, Storage), By Source (Umbilical Cord Blood, Bone Marrow, Peripheral Blood Stem, Menstrual Blood), By Indication (Cerebral Palsy, Thalassemia, Leukemia, Diabetes, Autism), By Geography (North America, Europe, Asia-Pacific, South America, Rest of the World) – Trends and Forecast to 2022
Media Contact
Company Name: Data Bridge Market Research Private Limited
Contact Person: Shubham Dwivedi
Email:Send Email
Phone: +1-888-387-2818
Address:Mega Center, Magarpatta City
City: Pune
State: Maharashtra
Country: India
Website: http://databridgemarketresearch.com/reports/global-self-injections-market-trends-forecast-2022/
